Get 20% lifetime commission for referring investors to digrin.com
here.
Organogenesis Holdings Inc. (ORGO) Financials
ORGO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 406.4 million | 118.3 million |
| March 31, 2026 | 520.0 million | 138.6 million |
| Dec. 31, 2025 | 598.7 million | 164.8 million |
| Sept. 30, 2025 | 509.8 million | 123.8 million |
ORGO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -32.8 million | 3.1 million |
| March 31, 2026 | 18.0 million | 3.6 million |
| Dec. 31, 2025 | 34.8 million | 4.3 million |
| Sept. 30, 2025 | 844000 | 3.1 million |
ORGO Net Income
No data available :(
ORGO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 46.1 million | - | 67.0 million |
| March 31, 2026 | 92.1 million | - | 61.1 million |
| Dec. 31, 2025 | 93.7 million | 50.7 million | 63.5 million |
| Sept. 30, 2025 | 64.4 million | - | 31.0 million |
ORGO Shares Outstanding
ORGO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 1.1 million | 18.3 million | 54.0 million | - |
| March 31, 2026 | 3.1 million | 15.2 million | 65.2 million | - |
| Dec. 31, 2025 | 4.7 million | 10.3 million | 100.2 million | - |
| Sept. 30, 2025 | 2.2 million | 13.2 million | 79.7 million | - |
ORGO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 43.8 million | 23.7 million |
| March 31, 2026 | 37.2 million | 38.1 million |
| Dec. 31, 2025 | 225.1 million | 49.9 million |
| Sept. 30, 2025 | 150.5 million | 36.3 million |
ORGO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ORGO
Price: $1
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.79 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 317113
Market Capitalization: 171.1 million